Ranolazine 1000 mg/1 (Ranolazine TABLET, EXTENDED RELEASE) 1000 mg/1

Ranolazine 1000 mg extended-release tablets are designed to support cardiovascular health. This medication is commonly used to manage chronic angina and improve exercise tolerance.

Strength

1000 mg/1

Pack Size

60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-126-02)

Manufacturer / TM Owner

Ajanta Pharma USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ranolazine is primarily used to treat chronic angina, a condition characterized by chest pain due to reduced blood flow to the heart. It works by improving blood flow and reducing the workload on the heart, which can help manage symptoms and improve exercise capacity. People often ask, 'What is Ranolazine used for?' and the answer is that it is typically prescribed for long-term angina management.

Side Effects

Common effects of Ranolazine may include dizziness, headache, and nausea. Some users also report constipation or fatigue. These effects vary among individuals and are not experienced by everyone who takes the medication.

Precautions & Warnings

Ranolazine should be handled with care, especially for those with liver or kidney issues. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping the medication. Always store the tablets in a cool, dry place away from direct sunlight.

Avoid Interactions

Ranolazine may interact with other medications, particularly those metabolized by the liver. It is advisable to avoid alcohol while taking Ranolazine, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Ranolazine is used to manage chronic angina and improve exercise tolerance by enhancing blood flow to the heart.

Ranolazine is typically taken orally, with or without food, as directed by a healthcare provider.

Common side effects may include dizziness, headache, nausea, constipation, and fatigue.

Ranolazine may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Ranolazine should be stored in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.